EMEA Amends Quality Review of Documents Templates

International Pharmaceutical Regulatory Monitor
A A
Drugmakers using the European Medicines Agency’s (EMEA) centralized procedure to submit new applications for marketing authorizations should comply with a revision of the Quality Review of Documents (QRD) template as soon as possible, the agency says. Includes the full text of EC Guideline on Summary of Product Characteristics.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00